Glenmark - Latest News on Glenmark | Read Breaking News on Zee News

Glenmark faces patent infringement suit for cancer drug in US

Last Updated: Tuesday, December 31, 2013, 15:44

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.

Glenmark gets USFDA nod for skin infections cream

Last Updated: Monday, September 30, 2013, 13:52

Glenmark Pharmaceuticals today said it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections.

Glenmark gets USFDA nod for alcohol abstinence drug

Last Updated: Monday, August 12, 2013, 14:16

Glenmark Pharmaceuticals today said it has received US health regulator`s approval to market generic version of Forest Laboratories` Campral Delayed Release Tablets, a drug used for alcohol abstinence, in the American market.

Glenmark gets USFDA approval for sclerosis treatment drug

Last Updated: Wednesday, June 19, 2013, 13:29

Drug firm Glenmark Pharmaceuticals today said it has received US health regulator`s approval to market Riluzole tablets, used in treating nervous system disorder, in the American market.

Glenmark recalls three drugs from US market

Last Updated: Thursday, May 23, 2013, 18:45

Glenmark Generics, a subsidiary of Glenmark Pharmaceuticals, is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US Food and Drug Administration.

Glenmark gets USFDA approval for headache drug

Last Updated: Wednesday, May 15, 2013, 18:45

Glenmark Pharmaceuticals Ltd today said its subsidiary has received approval from the US health regulator to sell generic versions of AstraZeneca`s Zomig and Zomig ZMT tablets, a migraine drug.

Glenmark gets tentative nod from USFDA for migraine tablets

Last Updated: Thursday, September 20, 2012, 16:26

Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its generic Rizatriptan Benzoate tablets used for treating migraine attacks.

Glenmark enters phase II trial for new drug molecule

Last Updated: Thursday, September 13, 2012, 17:53

Drug maker Glenmark Pharmaceuticals today said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.

First Prev 1 2 Next Last